OncoArendi starts clinical trial of novel asthma drug

…that a Polish firm has taken an innovative medicine into clinical trials, Mr Pikul noted As Mr Szumowski told Puls Biznesu, OncoArendi plans to advance the molecule to Phase II clinical trials before signing an out-licensing deal with a partner. This could happen within two years.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.